CSI Market
Sign In | Register

Celgene (CELG) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CELG Annual Cash Flow →
Cash flow performance over multiple periods helps investors evaluate the stability of Celgene's cash-generating activities.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2019)
9 Months 		(Jun 30 2019) (Mar 31 2019) (Dec 31 2018) (Sep 30 2018)
Operating Activities
Income4,807.00
Depreciation & amortization142.00
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability-18.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories7.00
Minority interests0.00
Gain (Loss) on Disposition of Business0.00
Share-based Compensation658.00
Income from affiliates0.00
Tax benefit on stock options0.00
Amortization Of Deferred Charges344.00
Reclassification Adjustment For Cash Flow Hedges-
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability-
Equity In Losses Of Affiliated Companies-
Amortization Expense-
Available For Sale Securities Gross Realized Gain Loss Net-
Payments For Contingent Consideration Operating Activities-
Increase Decrease of Contingent Consideration-29.00
Derivative Gain Loss On Derivative Net31.00
Income taxes245.00
Increase (Decrease) in Trading Securities100.00
Increase (Decrease) in Accounts Receivable-331.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities84.00
Accrued liabilities0.00
Deferred revenue0.00
Prepaid expenses0.00
Other Working Capital-100.00
Other Noncash Income (Expense)-74.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-51.00
Discontinued operations0.00
Net Cash flow from Operating Activities5,815.00
Investing Activities
Capital Expenditures-597.00
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Available-for-sale Securities976.00
Short-term Investments Acq.-473.00
Proceeds from other investments0.00
Purchases of other investments0.00
Noncontrolling interest0.00
Proceeds from Investments0.00
Payments to Acquire Other Investments-107.00
Purchases of non-current assets0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Investment in affiliate0.00
Sale of businesses0.00
Proceeds from sale of assets0.00
Notes receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-201.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-500.00
Noncontrolling interest0.00
Issuances / -repurchases of Comm. Stock363.00
Exercise of stock options0.00
Issuances / -repurchases of Pref. Stock0.00
Discontinued Operations0.00
Other financing activities net0.00
Other net0.00
Proceeds From Sale of Common Equity Put Options-82.00
Dividends paid to minority interests0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-219.00
Effect of exchange rate on cash flow-25.00
Discontinued operations0.00
Free Cash Flow5,218.00
Total Cash Flow5,370.00
4 historic quarters locked

Sign in to unlock the full Celgene cash flow history.

Sign In Create Free Account

About CELG Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.